TroSpas

/ CTS

15 mg (one TroSpas 15 mg tablet or half a TroSpas 30 mg tablet), 3 times a day (morning, noon and evening).
Or 30 mg in the morning (two TroSpas 15 mg tablets or one TroSpas 30 mg tablet) and 15 mg in the evening (one TroSpas 15 mg or half a TroSpas 30 mg tablet).
Patients with impaired kidney function: With severe renal failure (creatinine clearance 10-30 ml/ min/ 1.73 m²), do not exceed a maximal daily dosage of 15 mg.
Patients with impaired liver function: There is no need to adjust the dosage in cases of mild and moderate impairment of liver function. The treatment is not recommended in cases of severe impairment in liver function.
Children: Treatment is not recommended for children under 12 years of age, due to lack of data about this age group.
Method of administration: TroSpas 15 mg: swallow the tablet whole with a sufficient amount of water, at least one hour before a meal, on an empty stomach.
TroSpas 30 mg: swallow the tablet or half the tablet whole with a sufficient amount of water, at least one hour before a meal, on an empty stomach. Only TrosPas 30 mg tablets can be halved.
There is no information regarding crushing, pulverization or chewing of the tablets.
See package insert (OTC).

This medicine is used for treatment of impaired function of the urinary bladder, manifested by urgency and/or frequency and/or urinary incontinence.

Do not use this medicine if:
• You are sensitive (allergic) to the active ingredient or to any of the other ingredients this medicine contains.
You are suffering from:
• Urinary retention (urination is less frequent than usual).
• Narrow-angle glaucoma.
• Arrhythmia (rapid and irregular heartbeat).
• Myasthenia gravis.
• Severe chronic inflammatory bowel disease (Crohn’s disease, ulcerative colitis).
• Toxic megacolon.
• Renal disease requiring dialysis (creatinine clearance < 10 ml/min/1.73 m²).